Article
Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
Schizophrenia bulletin - 1 Nov 2015
Zhang Jian-Ping, Robinson Delbert G, Gallego Juan A, John Majnu, Yu Jin, Addington Jean, Tohen Mauricio, Kane John M, Malhotra Anil K, Lencz Todd
Abstract excerpt
Findings from the Psychiatric Genomics Consortium genome-wide association study (GWAS) showed that variation at the DRD2 locus is associated with schizophrenia risk. However, the functional significance of rs2514218, the top DRD2 single nucleotide polymorphism in the GWAS, is unknown. Dopamine D2 receptor binding is a common mechanism of action for all antipsychotic drugs, and DRD2 variants were related to...
Topics
- Adolescent
- Adult
- Antipsychotic Agents
- Aripiprazole
- Female
- Genetic Loci
- Humans
- Male
